| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |